Inventor
DELFINO FRANK
US21 patents
Patents
21 patentsUS10772972B2Sep 15, 2020
Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
REGENERON PHARMA44 citations97
US11384153B2Jul 12, 2022
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
REGENERON PHARMA16 citations92
US9475875B2Oct 25, 2016
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA14 citations92
US11129903B2Sep 28, 2021
Multispecific antigen-binding molecules and uses thereof
REGENERON PHARMA8 citations81
US10738124B2Aug 11, 2020
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA3 citations73
US11633501B2Apr 25, 2023
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof
REGENERON PHARMA3 citations72
US11414494B2Aug 16, 2022
Anti-GITR antibodies and uses thereof
REGENERON PHARMA3 citations72
US10738126B2Aug 11, 2020
Anti-GITR antibodies and uses thereof
REGENERON PHARMA4 citations72
US11352446B2Jun 7, 2022
Methods of making multispecific antigen-binding molecules
REGENERON PHARMA4 citations71
US11191844B2Dec 7, 2021
Multispecific antigen-binding molecules and uses thereof
REGENERON PHARMA4 citations70
US10806780B2Oct 20, 2020
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
REGENERON PHARMA4 citations70
US11866502B2Jan 9, 2024
Anti-FGFR2 antibodies and methods of use thereof
REGENERON PHARMA0 citations62
US11608380B2Mar 21, 2023
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA0 citations62
US10047160B2Aug 14, 2018
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA1 citations62
US12583939B2Mar 24, 2026
Bispecific antigen binding molecules that bind HER2, and methods of use thereof
REGENERON PHARMA0 citations60
US12297257B2May 13, 2025
Multispecific antigen-binding molecules and uses thereof
REGENERON PHARMA0 citations60
US12258412B2Mar 25, 2025
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies
REGENERON PHARMA0 citations60
US11958910B2Apr 16, 2024
Bispecific antigen binding molecules that bind HER2, and methods of use thereof
REGENERON PHARMA1 citations60
US12115216B2Oct 15, 2024
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
REGENERON PHARMA0 citations59
US11559576B2Jan 24, 2023
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
REGENERON PHARMA1 citations59
US12150959B2Nov 26, 2024
Chimeric antigen receptors with BCMA specificity and uses thereof
REGENERON PHARMA0 citations56